Biotech

All Articles

Praxis epilepsy drug lowers seizures in period 2 trial

.Praxis Preciseness Medicines has actually scored one more midphase succeed in epilepsy this year, a...

Three officers surrender as Dyne messages blended data for DMD candidate

.After getting away a medical grip a number of years back, Dyne Rehab has actually revealed new stag...

Arrowhead fires off phase 3 records in rare metabolic disease in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has presented its own give in advance of a possible face-off along with I...

Pfizer, Valneva reveal lyme ailment chance successful for 2nd booster

.Pfizer and Valneva may have about 2 even more years to hang around prior to they produce the 1st ap...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's dive into a discussion with Ayla Ellison, Strong Biotech Editor-in-Chief and Michelle Benz as...

New records show how Bayer's asundexian neglected to prevent movements

.Bayer put on hold the phase 3 test for its variable XIa prevention asundexian late in 2014 after th...

Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials

.Sanofi is actually still bented on taking its a number of sclerosis (MS) med tolebrutinib to the FD...

Galapagos' stockpile as fund presents intent to mold its advancement

.Galapagos is coming under additional stress coming from real estate investors. Having constructed a...

Cell- focused Sana gathers first CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable management hirings, shootings as...

Allist settles Jacobio $21M, landing function in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has bought itself a starring role in China's KRAS market, paying ou...